XDA Developers on MSN
The best value GPU for Plex transcoding is way different (and older) than you'd expect
Discrete GPUs also offer flexibility beyond Plex. If your server doubles as a workstation, runs machine learning workloads, or handles other GPU-accelerated tasks, the additional horsepower isn’t ...
Thanks to the Raspberry Pi, we have easy access to extremely inexpensive machines running Linux that have all kinds of GPIO ...
If you're looking to break away from third-party file and directory storage, this model from Terramaster checks most boxes for me.
DOVER, Del., Dec. 29, 2025 (GLOBE NEWSWIRE) -- UnifyDrive, an innovator in network storage solutions, today announced the ...
XDA Developers on MSN
Old laptops make better home servers than most people realize
Turn that dusty old laptop into a quiet, capable home server that can handle media, backups, and self-hosted apps with ease.
BOSTON - TransCode Therapeutics, Inc. (NASDAQ:RNAZ), a micro-cap biotech company with a market capitalization of just $7.91 million, and Quantum Leap Healthcare Collaborative announced Thursday a ...
BOSTON, Dec. 11, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) and Quantum Leap Healthcare Collaborative ("Quantum Leap") today announce a new collaboration to evaluate TransCode's ...
CK Life Sciences International is set to merge its subsidiary Polynoma with Nasdaq-listed TransCode Therapeutics, in a move expected to boost the pipeline of anticancer drugs, according to the biotech ...
(RTTNews) - TransCode Therapeutics (RNAZ) has entered into a definitive agreement to acquire Polynoma, a privately-held biotechnology immuno-oncology company. Polynoma is developing a late-stage ...
In a pair of deals, TransCode Therapeutics has bagged Polynoma and its phase 3 cancer vaccine, as well as a $25 million injection into its cash-strapped coffers—but in doing so, the company is trading ...
TransCode expands its microRNA-based pipeline with Polynoma's Phase 3-ready seviprotimut-L, a novel polyvalent shed antigen vaccine for the adjuvant treatment of melanoma Philippe Calais, PharmD, PhD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results